NIH Seeks Proposals for 2009 Director's Pioneer and New Innovator Awards
NIH welcomes proposals for 2009 NIH Director's Pioneer Awards and New Innovator Awards. Both programs are part of the NIH Roadmap for Medical Research and support exceptionally creative scientists who take highly innovative, potentially high-impact approaches to major challenges in biomedical or behavioral research.
Pioneer Awards provide up to $2.5 million in direct costs over five years and are open to scientists at any career stage. New Innovator Awards provide up to $1.5 million in direct costs over the same period and are for early career investigators who have not received an NIH regular research (R01) or similar NIH grant.
NIH expects to make five to 10 Pioneer Awards and up to 24 New Innovator Awards in September 2009.
To continue its strong record of diversity in these programs, NIH especially encourages women and members of groups that are underrepresented in NIH research to apply.
Starting this year, both the Pioneer Award and the New Innovator Award competitions will begin with a pre-application phase:
The Pioneer Award competition begins with a proposal submission period from Nov. 17 to Dec. 17, 2008. See Pre-Application for the 2009 NIH Director’s Pioneer Award Program (X02) (PAR-09-012) for instructions and for more information. Send questions to pioneer@nih.gov.
The New Innovator Award competition begins with a proposal submission period from Dec. 15, 2008 to Jan. 15, 2009. See Pre-Application for the 2009 NIH Director’s New Innovator Award Program (X02)
(PAR-09-013) for instructions and for more information. Send questions to newinnovator@nih.gov.
New! Transformative R01 Program
The NIH’s new Transformative R01 Program (T-R01s) will allow highly creative, “out-of-the-box” projects to be supported. The T-R01 Program represents a High Risk/High Reward Demonstration Project in which novel approaches to peer review and program management are to be piloted.
The application submission period is from Dec. 29, 2008 to Jan. 29, 2009. More information. Send questions to T_R01@mail.nih.gov.
The NIH Roadmap for Medical Research, launched in 2004, is a series of initiatives designed to address fundamental knowledge gaps, develop transformative tools and technologies, and/or foster innovative approaches to complex problems. Funded through the NIH Common Fund, these programs cut across the missions of individual NIH institutes and centers (ICs) and are intended to accelerate the translation of research to improvements in public health. OPASI, in collaboration with all NIH ICs, oversees programs funded by the Common Fund. See additional information about the NIH Roadmap and Common Fund
The National Institutes of Health (NIH) – “The Nation's Medical Research Agency” – includes 27 institutes and centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.
|